Lincoln Pharmaceuticals Ltd

NSE: LINCOLN · BSE: 531633 · Pharmaceuticals & Biotechnology · 5 announcements

Share price: ₹591.00
Market cap: ₹1,184 Cr
Revenue (annual): ₹671.0 Cr
Net profit (annual): ₹87.89 Cr
P/E (TTM): 12.3×Sector 50.4×
Promoter holding: 49.78%+0.00% QoQ
FII holding: 4.60%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Other Announcement 1 Management Change 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

24 Sep 2026 14:08 IST BSE

Management Change

Lincoln Pharmaceuticals Management Change

Lincoln Pharmaceuticals announced the resignation of Mr. Manoj Rai, Sr. General Manager (Head QA), a Senior Management Personnel. He departs effective 24 September 2026 for personal reasons.

Read the filing ↗